NTHI (STOCKS)
NeOnc Technologies Holdings, Inc. Common Stock
$5.300000
-0.140000 (-2.57%)
Prev close: $5.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Amir Farrokh Heshmatpour
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $126.77M
- Employees
- 5
- P/E (TTM)
- -1.49
- P/B (TTM)
- -6.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.73 | $-0.38 | -0.3526 | -93.43% |
Financial Statements
| Revenues | $39.99K |
| Benefits Costs and Expenses | $62.19M |
| Costs And Expenses | $62.19M |
| Operating Expenses | $58.28M |
| Research and Development | $3.64M |
| Other Operating Expenses | $54.64M |
| Operating Income/Loss | -$58.24M |
| Income/Loss From Continuing Operations After Tax | -$62.15M |
| Income/Loss From Continuing Operations Before Tax | -$62.15M |
| Interest Expense, Operating | $2.50M |
| Net Income/Loss | -$62.15M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$62.15M |
| Net Income/Loss Available To Common Stockholders, Basic | -$62.15M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.20 |
| Diluted Earnings Per Share | -$3.20 |
| Basic Average Shares | 19,398,776 |
| Diluted Average Shares | 19,398,776 |
| Assets | $2.82M |
| Current Assets | $1.39M |
| Noncurrent Assets | $1.43M |
| Liabilities | $20.33M |
| Current Liabilities | $20.04M |
| Wages | $255.10K |
| Other Current Liabilities | $19.79M |
| Noncurrent Liabilities | $290.68K |
| Equity | -$17.51M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$17.51M |
| Liabilities And Equity | $2.82M |
| Net Cash Flow From Operating Activities | -$20.36M |
| Net Cash Flow From Operating Activities, Continuing | -$20.36M |
| Net Cash Flow From Investing Activities | -$493.84K |
| Net Cash Flow From Investing Activities, Continuing | -$493.84K |
| Net Cash Flow From Financing Activities | $20.86M |
| Net Cash Flow From Financing Activities, Continuing | $20.86M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$62.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$62.15M |
| Other Comprehensive Income/Loss | $0.00 |